Viewing Study NCT01876966

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:07 PM
Ignite Modification Date: 2026-02-20 @ 1:41 PM
Study NCT ID: NCT01876966
Status: COMPLETED
Last Update Posted: 2013-06-13
First Post: 2012-11-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine
Sponsor: Janssen Pharmaceutica N.V., Belgium
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV View
None pharmacokinetic interaction View
None healthy HIV-negative person View